Loading...
XNAS
RDNT
Market cap5.36bUSD
Oct 08, Last price  
68.21USD
1D
-0.58%
1Q
3.98%
Jan 2017
957.52%
IPO
2,336.07%
Name

RadNet Inc

Chart & performance

D1W1MN
XNAS:RDNT chart
P/E
—
P/S
2.63
EPS
—
Div yield, %
—
Shrs. gr., 5y
8.12%
Rev. gr., 5y
13.74%
Revenues
2.04b
+11.51%
161,005,000425,470,000502,118,000524,368,000548,537,000619,800,000647,153,000702,986,000717,569,000809,628,000884,535,000922,186,000975,146,0001,154,179,0001,071,840,0001,315,077,0001,430,061,0001,616,630,0001,829,664,0002,040,210,000
Net income
-19m
L
-6,894,000-18,131,000-12,836,000-2,267,000-12,852,0007,231,00064,517,0002,120,0001,376,0007,709,0007,230,00053,00032,243,00014,756,000-14,840,00024,727,00010,650,0003,044,0002,793,000-18,652,000
CFO
299m
+28.24%
10,251,00029,201,00045,201,00076,618,00066,884,00057,636,00074,033,00066,422,00061,004,00067,037,00091,599,000141,187,000116,754,000104,322,000233,759,000149,491,000146,417,000220,863,000233,023,000298,820,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.

Key people

Howard Berger
Chairman of the Board, President, Chief Executive Officer · since 2011
Stephen Forthuber
President, Chief Operating Officer- Eastern Operations · since 2017
Norman Hames
President, Chief Operating Officer - Western Operations · since 2019
Cornelis Wesdorp
President and Chief Executive Officer - Digital Health Segment · since 2024
Mital Patel
Executive Vice President - Financial Planning and Analysis, Chief Administrative Officer · since 2021
Michael Murdock
Executive Vice President - Mergers and Acquisitions · since 2021
Chief Financial Officer, Executive Vice President · since 2004
Christine Gordon
Senior Vice President - Operations, Northern California, Director · since 2021
Ranjan Jayanathan
Executive Vice President, Chief Information Officer · since 2021
David Katz
Executive Vice President, Chief Legal Officer, Corporate Secretary · since 2021
Director and Chief Science Officer · since 2023
Laura Jacobs
Independent Director · since 2020
Lawrence Levitt
Independent Director · since 2005
Gregory Spurlock
Independent Director · since 2021
David Swartz
Lead Independent Director · since 2011
IPO date
Dec 12, 2001
Employees
9,000
Domiciled in
US
Incorporated in
US
Legal address
c/o CORPORATION SERVICE COMPANY, 251 LITTLE FALLS DRIVE
WILMINGTON, DE 19808
US
Headquarters
1510 COTNER AVE
LOS ANGELES, CA 90025
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT